TY - JOUR
T1 - Heterogeneous Liver on Research Ultrasound Identifies Children with Cystic Fibrosis at High Risk of Advanced Liver Disease
T2 - Interim Results of a Prospective Observational Case-Controlled Study
AU - CFLD Network
AU - Siegel, Marilyn J.
AU - Freeman, A. Jay
AU - Ye, Wen
AU - Palermo, Joseph J.
AU - Molleston, Jean P.
AU - Paranjape, Shruti M.
AU - Stoll, Janis
AU - Leung, Daniel H.
AU - Masand, Prakash
AU - Karmazyn, Boaz
AU - Harned, Roger
AU - Ling, Simon C.
AU - Navarro, Oscar M.
AU - Karnsakul, Wikrom
AU - Alazraki, Adina
AU - Schwarzenberg, Sarah Jane
AU - Seidel, Frank Glen
AU - Towbin, Alex
AU - Alonso, Estella M.
AU - Nicholas, Jennifer L.
AU - Murray, Karen F.
AU - Otto, Randolph K.
AU - Sherker, Averell H.
AU - Magee, John C.
AU - Narkewicz, Michael R.
N1 - Funding Information:
Funded by grants from the Cystic Fibrosis Foundation (NARKEW17AB0 [to M.N.]) and NIDDK ( U01 DK062453 [to M.N.] and U01 DK 062456 [to J.M.]). S.S. serves as a consultant for AbbVie. M.N. serves as a consultant for Vertex, has received research grants from Gilead , AbbVie , and has a family member with stock in AbbVie and Merck . The other authors declare no conflicts of interest. Original Article
Funding Information:
Funded by grants from the Cystic Fibrosis Foundation (NARKEW17AB0 [to M.N.]) and NIDDK (U01 DK062453 [to M.N.] and U01 DK 062456 [to J.M.]). S.S. serves as a consultant for AbbVie. M.N. serves as a consultant for Vertex, has received research grants from Gilead, AbbVie, and has a family member with stock in AbbVie and Merck. The other authors declare no conflicts of interest.
Publisher Copyright:
© 2019 Elsevier Inc.
PY - 2020/4
Y1 - 2020/4
N2 - Objective: To assess if a heterogeneous pattern on research liver ultrasound examination can identify children at risk for advanced cystic fibrosis (CF) liver disease. Study design: Planned 4-year interim analysis of a 9-year multicenter, case-controlled cohort study (Prospective Study of Ultrasound to Predict Hepatic Cirrhosis in CF). Children with pancreatic insufficient CF aged 3-12 years without known cirrhosis, Burkholderia species infection, or short bowel syndrome underwent a screening research ultrasound examination. Participants with a heterogeneous liver ultrasound pattern were matched (by age, Pseudomonas infection status, and center) 1:2 with participants with a normal pattern. Clinical status and laboratory data were obtained annually and research ultrasound examinations biannually. The primary end point was the development of a nodular research ultrasound pattern, a surrogate for advanced CF liver disease. Results: There were 722 participants who underwent screening research ultrasound examination, of which 65 were heterogeneous liver ultrasound pattern and 592 normal liver ultrasound pattern. The final cohort included 55 participants with a heterogeneous liver ultrasound pattern and 116 participants with a normal liver ultrasound pattern. All participants with at least 1 follow-up research ultrasound were included. There were no differences in age or sex between groups at entry. Alanine aminotransferase (42 ± 22 U/L vs 32 ± 19 U/L; P = .0033), gamma glutamyl transpeptidase (36 ± 34 U/L vs 15 ± 8 U/L; P < .001), and aspartate aminotransferase to platelet ratio index (0.7 ± 0.5 vs 0.4 ± 0.2; P < .0001) were higher in participants with a heterogeneous liver ultrasound pattern compared with participants with a normal liver ultrasound pattern. Participants with a heterogeneous liver ultrasound pattern had a 9.1-fold increased incidence (95% CI, 2.7-30.8; P = .0004) of nodular pattern vs a normal liver ultrasound pattern (23% in heterogeneous liver ultrasound pattern vs 2.6% in normal liver ultrasound pattern). Conclusions: Research liver ultrasound examinations can identify children with CF at increased risk for developing advanced CF liver disease.
AB - Objective: To assess if a heterogeneous pattern on research liver ultrasound examination can identify children at risk for advanced cystic fibrosis (CF) liver disease. Study design: Planned 4-year interim analysis of a 9-year multicenter, case-controlled cohort study (Prospective Study of Ultrasound to Predict Hepatic Cirrhosis in CF). Children with pancreatic insufficient CF aged 3-12 years without known cirrhosis, Burkholderia species infection, or short bowel syndrome underwent a screening research ultrasound examination. Participants with a heterogeneous liver ultrasound pattern were matched (by age, Pseudomonas infection status, and center) 1:2 with participants with a normal pattern. Clinical status and laboratory data were obtained annually and research ultrasound examinations biannually. The primary end point was the development of a nodular research ultrasound pattern, a surrogate for advanced CF liver disease. Results: There were 722 participants who underwent screening research ultrasound examination, of which 65 were heterogeneous liver ultrasound pattern and 592 normal liver ultrasound pattern. The final cohort included 55 participants with a heterogeneous liver ultrasound pattern and 116 participants with a normal liver ultrasound pattern. All participants with at least 1 follow-up research ultrasound were included. There were no differences in age or sex between groups at entry. Alanine aminotransferase (42 ± 22 U/L vs 32 ± 19 U/L; P = .0033), gamma glutamyl transpeptidase (36 ± 34 U/L vs 15 ± 8 U/L; P < .001), and aspartate aminotransferase to platelet ratio index (0.7 ± 0.5 vs 0.4 ± 0.2; P < .0001) were higher in participants with a heterogeneous liver ultrasound pattern compared with participants with a normal liver ultrasound pattern. Participants with a heterogeneous liver ultrasound pattern had a 9.1-fold increased incidence (95% CI, 2.7-30.8; P = .0004) of nodular pattern vs a normal liver ultrasound pattern (23% in heterogeneous liver ultrasound pattern vs 2.6% in normal liver ultrasound pattern). Conclusions: Research liver ultrasound examinations can identify children with CF at increased risk for developing advanced CF liver disease.
KW - cirrhosis
KW - cystic fibrosis liver disease
UR - http://www.scopus.com/inward/record.url?scp=85081659573&partnerID=8YFLogxK
U2 - 10.1016/j.jpeds.2019.12.033
DO - 10.1016/j.jpeds.2019.12.033
M3 - Article
C2 - 32061406
AN - SCOPUS:85081659573
SN - 0022-3476
VL - 219
SP - 62-69.e4
JO - Journal of Pediatrics
JF - Journal of Pediatrics
ER -